Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Neoplasms 2Cancer Cachexia 2Pancreatic Neoplasms 1Mucositis 1Head and Neck Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

kang-lai-te 2ruxolitinib 1macimorelin 1RC-1291 1Pharmacogenomic Testing 1Omacor 1Nutrition Assessment 1Isophane Insulin, Human 1Eicosapentaenoic Acid 1Docosahexaenoic Acids 1Capsules 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Cancer Cachexia × kang-lai-te × Clear all
NCT03631459 2018-08-21

A Multicenter Real World Study of Kanglaite for Cancer Cachexia

Zhejiang Kanglaite Pharmaceutical Co.Ltd

Unknown
100,000 enrolled

Cancer Cachexia

NCT02553187 2017-02-15

A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia

Zhejiang Kanglaite Pharmaceutical Co.Ltd

Phase 4 Unknown
160 enrolled

Cancer Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡